COVID-19 is disrupting K-12 systems, affecting learning and other essential school-based services. The Strategic Digital Learning Initiative is offering seed grants to support innovative and timely research and design efforts focused on K-12.
Seed funding is available to kickstart the development of strategic new research directions in areas where the Linac Coherent Ligh Source (LCLS) at SLAC could provide transformational insight into long-standing science or engineering challenges.
Stanford AIMI, in collaboration with Google Cloud, is offering Stanford researchers the opportunity to receive up to $20,000 per year of Google Cloud research credits on any Google Cloud product for research in the field of AI in medicine.
Stanford Impact Labs is currently accepting letters of interest for our second Impact Lab Start-Up Funding opportunity. Stanford Impact Labs makes 3-5 investments each cycle in start-up Impact Labs.
These pilot grants are intended to support the advancement of research into the impact of COVID-19 on the wellbeing, health service use, and health outcomes of populations that experience health disparities in the United States.
The Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. This RFP seeks to leverage Stanford infrastructure to address the COVID-19 pandemic
The Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. This RFP seeks to leverage Stanford infrastructure to address the COVID-19 pandemic
Stanford ChEM-H is soliciting seed grant proposals from postdoc teams for exploratory projects that align with the Institute’s mission to bridge chemistry or engineering with biomedical sciences or medicine.
Stanford AIM is seeking target-driven drug discovery proposals with compelling therapeutic rationale, identified protein target amenable to therapeutic intervention, and sufficient evidence for a drug discovery effort from PI-eligible faculty.
